Sascha Dublin to Angiotensin-Converting Enzyme Inhibitors
This is a "connection" page, showing publications Sascha Dublin has written about Angiotensin-Converting Enzyme Inhibitors.
Connection Strength
1.220
-
Renin-Angiotensin-Aldosterone System Inhibitors and COVID-19 Infection or Hospitalization: A Cohort Study. Am J Hypertens. 2021 04 20; 34(4):339-347.
Score: 0.718
-
Angiotensin-converting enzyme inhibitor use and pneumonia risk in community-dwelling older adults: results from a population-based case-control study. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1173-82.
Score: 0.395
-
Antihypertensive treatment with ACE inhibitors or beta-blockers and risk of incident atrial fibrillation in a general hypertensive population. Am J Hypertens. 2009 May; 22(5):538-44.
Score: 0.077
-
Use of statins and antihypertensive medications in relation to risk of long-standing persistent atrial fibrillation. Ann Pharmacother. 2015 Apr; 49(4):378-86.
Score: 0.029